➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKinsey
Moodys
Boehringer Ingelheim
Harvard Business School

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

Claims for Patent: 5,489,436


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,489,436
Title: Taste mask coatings for preparation of chewable pharmaceutical tablets
Abstract:Chewable tablets are made from a coated medicament wherein the coating comprises a mixture of dimethylaminoethyl methacrylate and neutral methacrylic acid ester and a cellulose ester, e.g. cellulose acetate, cellulose acetate butyrate, cellulose triacetate or a combination thereof and optionally polyvinyl pyrrolidone, and a process for making such tablets and a method of providing taste masking and sustained releasing of medicaments utilizing such coatings.
Inventor(s): Hoy; Michael R. (Sellersville, PA), Roche; Edward J. (Paoli, PA)
Assignee: McNeil-PPC, Inc. (Milltown, NJ)
Application Number:08/166,111
Patent Claims: 1. A chewable medicament tablet comprising a medicament composition coated with a taste masking effective amount of a polymer blend consisting essentially of from about 5 to about 95 weight percent by total weight of the polymer blend of dimethylaminoethyl methacrylate and neutral methacrylic acid ester and from about 5 to about 95 percent by total weight of the polymer blend of a polymer selected from the group consisting of cellulose acetate, cellulose triacetate or a combination thereof.

2. The chewable tablet of claim 1 wherein the polymer blend coating comprises from about 2 to 55% by weight of the total weight of the coated medicament composition.

3. The chewable tablet of claim 1 wherein the polymer blend consists essentially of about 10 to about 90% of dimethylaminoethyl methacrylate and neutral methacrylic acid ester and about 10 to about 90% of cellulose acetate or cellulose triacetate, by weight of the total weight of the polymer blend.

4. The chewable tablet of claim 1 wherein the medicament composition to be coated is spherical in shape.

5. The chewable tablet of claim 2 wherein the medicament composition comprises a medicament selected from the group consisting of acetaminophen, ibuprofen, dexibuprofen lysinate, naproxen, naproxen sodium, psyllium, chlorpheniramine, astemizole, loperamide, famotidine, ranitidine, cimetidine, pseudoephedrine, salts thereof and combinations thereof.

6. The chewable tablet of claim 3 wherein the medicament is selected-from the group consisting of acetaminophen, ibuprofen, dexibuprofen lysinate, naproxen, naproxen sodium, psyllium, chlorpheniramine, astemizole, loperamide, famotidine, ranitidine, cimetidine, pseudoephedrine, salts thereof and combinations thereof.

7. The chewable tablet of claim 6 wherein the tablet additionally comprises pharmaceutically acceptable excipients.

8. A process of preparing a chewable medicament tablet comprising the steps of:

coating a medicament composition with a taste masking effective amount of polymer blend consisting essentially of about 5 to about 95 weight percent by total weight of the polymer blend of dimethylaminoethyl methacrylate and neutral methacrylic acid ester and about 5 to about 95 weight percent by total weight of the polymer blend of a polymer selected from the group consisting of cellulose acetate, cellulose triacetate and combinations thereof; and forming a chewable tablet by compressing the coated medicament composition in the presence of excipients.

9. The process of claim 8, further comprising the step of granulating the medicament to form said medicament composition.

10. The process of claim 8 wherein the polymer coating comprises from 2 to 55% by weight of total weight of the coated medicament composition.

11. A method for taste masking medicaments comprising coating a medicament composition with a taste masking effective amount of a polymer blend consisting essentially of from about 5 to about 95 weight percent by total weight of the polymer blend of dimethylaminoethyl methacrylate and neutral methacrylic acid ester and about 5 to about 95 weight percent by total weight of the polymer blend of a polymer selected from the group consisting of cellulose acetate, cellulose triacetate and combinations thereof.

12. The method of claim 11 wherein the medicament composition comprises a medicament selected from the group consisting of acetaminophen, ibuprofen, ibuprofen sodium, dexibuprofen lysinate, naproxen, naproxen sodium, psyllium chlorpheniramine, astemizole, loperamide, famotidine, ranitidine, cimetidine, pseudoephedrine salts thereof and combinations thereof.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Johnson and Johnson
Colorcon
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.